Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.35 |
| ▸ | HK1 | P19367 | 2/20 | 0.32 |
| ▸ | HK2 | P52789 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.32 |
| ▸ | CD69 | Q07108 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ribose (Furanose) SCHEMBL5827542 | 0.74 | TDP1 (0.44) | HK1HK2KDM4ESLC5A2 | |
| Ribose (Furanose) SCHEMBL502905 | 0.73 | KDM4C (0.37) | HK1HK2KDM4ESLC5A2 | |
| Ribose (Furanose) SCHEMBL17479515 | 0.73 | TDP1 (0.47) | TSHRKDM4ELMNA | |
| Ribose (Furanose) SCHEMBL502608 | 0.70 | TSHR (0.43) | TSHRHK1HK2KDM4ECYP2C19 | |
| SCHEMBL8973945 | 0.69 | PYGL (0.43) | SLC5A2 | |
| Ribose (Furanose) SCHEMBL19717961 | 0.67 | NAPRT (0.53) | TSHRHK1HK2CYP2D6CYP2C19 | |
| SCHEMBL5878336 | 0.67 | UMPS (0.44) | TSHRKDM4ELMNASLC5A2 | |
| SCHEMBL28317597 | 0.67 | TDP1 (0.50) | KDM4ELMNACYP2C19 | |
| Ribose (Furanose) SCHEMBL502577 | 0.66 | ALDH1A1 (0.58) | HK1HK2LMNA | |
| Ribose (Furanose) SCHEMBL25392429 | 0.66 | F7 (0.52) | HK1HK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017184885-A1 | USE OF NICOTINIC ACID RIBOSIDE OR NICOTINAMIDE RIBOSITE DERIVATIVES, AND REDUCED DERIVATIVES THEREOF, AS NAD+INCREASING PRECURSORS | ChromaDex Inc. (US) | 2017-10-26 | — | — | WO | disclosed |